Propofol Reversed Hypoxia-Induced Docetaxel Resistance in Prostate Cancer Cells by Preventing Epithelial–Mesenchymal Transition by Inhibiting Hypoxia-Inducible Factor 1<i>α</i>

<div>Propofol played a role in hypoxia-induced docetaxel resistance by decreasing HIF-1<i>α</i>. Western blot showing E-cadherin and vimentin expression in HIF-1<i>α</i>–knockdown prostate cancer cells under hypoxia treated with or without propofol.</div>

BioMed Research International

fig5

Figure 5

Figure 5: Propofol Reversed Hypoxia-Induced Docetaxel Resistance in Prostate Cancer Cells by Preventing Epithelial–Mesenchymal Transition by Inhibiting Hypoxia-Inducible Factor 1<i>α</i> 

Figure 5 | Propofol Reversed Hypoxia-Induced Docetaxel Resistance in Prostate Cancer Cells by Preventing Epithelial–Mesenchymal Transition by Inhibiting Hypoxia-Inducible Factor 1α 